ORKA vs TECH · $4.27B cap vs P/E 65, rev $1.22B
Oruka Therapeutics, Inc. (ORKA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Oruka Therapeutics, Inc. (ORKA) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ORKA revenue for 2024-06-30 was $0. Net income was -$22.2M. ORKA currently screens at market cap $4.27B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ORKA currently screens at market cap $4.27B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ORKA and TECH stock pages for the full models.
Not investment advice.